[1]
O. S. Kolomoets, “3’-R-Spiro[cycloalkyl-1(2), (hetaryl-3(4), 6’-[1,2,4]triazino[2,3-c]quinazoline]-2’(7’H)-2-оnes as a perspective class of compounds with actoprotective activity”, Zaporozhye Medical Journal, vol. 19, no. 2, Mar. 2017.